Iron Replacemant & Hematinics, Not Oral
PDL Status Values
Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the
Non-Preferred Drugs in Select PDL Classes prior authorization criteria.
New drugs will be listed as N until reviewed by the P&T Committee and are subject to the
New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.
To request a Prior Authorization, please use this form.
Generic Name | Brand Name | Form | PDL Status |
Current Drug Use Criteria | New Drug Evaluation |
---|---|---|---|---|---|
betibeglogene autotemcel | ZYNTEGLO | PLAST. BAG | N | PA Document | Oct 05, 2023 |
daprodustat | JESDUVROQ | TABLET | N | PA Document | Dec 07, 2023 |
exagamglogene autotemcel | CASGEVY | VIAL | N | PA Document | Jun 06, 2024 |
lovotibeglogene autotemcel | LYFGENIA | PLAST. BAG | N | PA Document | Jun 06, 2024 |
vadadustat | VAFSEO | TABLET | N | ||
atidarsagene autotemcel | LENMELDY | PLAST. BAG | |||
ferric carboxymaltose | INJECTAFER | VIAL | |||
ferric derisomaltose | MONOFERRIC | VIAL | |||
ferric pyrophosphate citrate | TRIFERIC | AMPUL | |||
ferumoxytol | FERAHEME | VIAL | |||
ferumoxytol | FERUMOXYTOL | VIAL | |||
iron sucrose complex | VENOFER | VIAL | |||
motixafortide acetate | APHEXDA | VIAL | |||
plerixafor | PLERIXAFOR | VIAL | |||
plerixafor | MOZOBIL | VIAL | |||
sodium ferric gluconat/sucrose | FERRLECIT | VIAL | |||
sodium ferric gluconat/sucrose | SOD FERRIC GLUCONATE COMPLEX | VIAL |